Doctors couldn’t explain what happened to him 25 years ago, until now
05:57, 26 Aug 2025Updated 06:21, 26 Aug 2025
Kate and Timothy Bingham(Image: National Institute for Health and Care Research)
Twenty-five years ago, when Timothy Bingham was just two-years-old, he started getting ill.
But his family weren’t too concerned, it was just a mild flu, or so they thought.
That mild flu left him unable to walk. And three years later, following another infection, he was paralysed and has been in a wheelchair ever since.
Doctors were never able to explain why Timothy was left with such tragic results from a mild bout of infection. It started a 25-year-long mystery – until now.
Never miss a story with the MEN’s daily Catch Up newsletter – get it in your inbox by signing up here
Kate Bingham, mum of Tim, who is now 28, explained: “About 25 years ago Tim got a flu-like infection and a temperature. What seemed like a minor illness had devastating consequences.
“The attack, and subsequent attacks – did terrible damage. First to his legs, then his arms, his face and his chest.
“And now he needs 24-hour care. His diaphragm barely works at all so he can’t cough.
“It’s hard for him to chew and he can’t drink unassisted.
“He can’t move in bed so needs turning throughout the night. The things we all take for granted he can’t do.”
Timothy with his dog, Red(Image: National Institute for Health and Care Research)
Then in 2011, doctors saw an eight-month-old girl at the Royal Manchester Children’s Hospital who had been completely fit and well – until a mild chest infection left her unable to breathe without the support of a ventilator.
They considered that there may be a genetic cause as her two brothers had experienced similar severe problems following mild infections.
Genetic researchers at the University of Manchester have now discovered that changes in a gene called RCC1 led to this severe nerve damage in both Timothy, who is from Cheltenham, and the family in Manchester.
A further 20 children from 10 families from the UK, Türkiye, Czechia, Germany, Iran, India, Saudi Arabia, Cyprus, and Slovakia have been found to have changes in the same gene leading to this severe nerve condition all triggered by mild infections.
In over half of the children, doctors suspected the diagnosis of a different severe nerve condition that can develop after infection called Guillain Barré syndrome.
Kate says this groundbreaking discovery has given families like hers answers at last. She said: “As Tim’s mum, the discovery of a gene which is linked to what happened to Tim means everything to me.
“For so long we have lived with uncertainty of not knowing the full picture.
“This breakthrough brings us great hope as it will do to all those people who have waited years for answers. This is something that helps us look to the future.
“I’m proud of how strong Tim has been. He now has a girlfriend he met online who is wonderful. He proves there is life beyond disability.”
Join the Manchester Evening News WhatsApp group HERE
The researchers performed laboratory studies on skin cells taken from patients and in specially genetically engineered fruit flies to show that the damage to nerves can be caused by certain chemicals.
Skin cells from patients, when looked at under special microscopes, have changes very similar to those seen in the cells of patients with motor neurone disease where muscles, including those controlling breathing and swallowing, become weak.
Bill Newman, Professor of Translational Genomic Medicine at the University of Manchester and Rare Conditions Co-Theme Lead at the NIHR Manchester Biomedical Research Centre, led the research. The study was published in the Lancet Neurology journal last month.
He said: “Until this study, little was known about why some people experience severe nerve damage after they have had a mild infection like flu or a stomach upset.
“This work provides families with an explanation and is the first step in us developing an effective treatment. As children are well before they develop nerve damage following an infection, this gives us an opportunity to treat at risk children before problems occur.
“The similarity with Guillain-Barré syndrome and with conditions like motor neurone disease may help us understand these more common conditions and why some people are at greater risk and what treatments may be effective.”
Sam Barrell, CEO of LifeArc, which helped to fund the research, said: “For many people living with rare conditions, the wait for a diagnosis can be agonisingly long – around a third wait more than five years.
“In Timothy’s case, that uncertainty stretched for over twenty years. This discovery provides a potential target for treatment and the first step towards delivering a brighter future for people that could be living with this same devastating condition.”